Tiger Management Llc acquired 30,200 shares as Quintiles Ims Holdings Inc (Q)'s stock rose 8.21%. The hedge fund held 38,700 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $3.44 million, down from 305,100 at the end of the previous reported quarter. Annex Advisory Services Llc who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $189.43 billion market cap company. About 5.83 million shares traded.
AbbVie Inc (ABBV) opened at $119.29 on Friday. It has underperformed by 6.07% the S&P500.
Connor Clark & Lunn Investment Management Ltd decreased its stake in Mag Silver (MVG) by 39.3% based on its latest 2017Q3 regulatory filing with the SEC. Trafelet Brokaw Capital Management Lp bought 243,389 shares as the company's stock rose 70.49% with the market. The institutional investor held 84,000 shares of the oil & gas production company at the end of 2017Q3, valued at $842,000, up from 29,000 at the end of the previous reported quarter. Landscape Capital Management Llc who had been investing in Retail Pptys Amer Inc for a number of months, seems to be less bullish one the $2.60B market cap company. The stock increased 3.70% or $0.32 during the last trading session, reaching $8.96. Mag Silver Corporation Oridinar (NYSEMKT:MVG) has 0.00% since March 11, 2017 and is. It has outperformed by 10.05% the S&P500.
AbbVie (NYSE:ABBV) last released its earnings results on Friday, January 26th. Therefore 44% are positive. Abbvie Inc had 79 analyst reports since July 21, 2015 according to SRatingsIntel. Leerink Swann initiated the stock with "Mkt Perform" rating in Tuesday, October 18 report. The firm has "Neutral" rating by Atlantic Securities given on Friday, December 18. Barclays Capital maintained AbbVie Inc. Citigroup upgraded it to " rating and $60 target in Monday, September 28 report. (NYSE:ABBV) has "Buy" rating given on Monday, June 26 by Jefferies.
AbbVie Inc (AbbVie) is a research-based biopharmaceutical company. Jefferies Group set a $145.00 target price on AbbVie and gave the stock a "buy" rating in a research note on Monday, February 26th. As per Wednesday, April 19, the company rating was maintained by BMO Capital Markets. (NYSE:ABBV). Jnba Fincl Advsrs has invested 0.22% in AbbVie Inc. As per Monday, June 6, the company rating was downgraded by Cowen & Co.
Since September 11, 2017, it had 0 insider buys, and 13 selling transactions for $49.94 million activity. 4,294 shares were sold by Michael Robert A., worth $512,853 on Wednesday, February 28. 8,300 shares were sold by SALEKI-GERHARDT AZITA, worth $705,655 on Monday, September 11. 8,280 shares valued at $976,084 were sold by GONZALEZ RICHARD A on Wednesday, February 28. $9.57 million worth of stock was sold by ALBAN CARLOS on Wednesday, February 28. (NYSE:ABBV). Denver Investment Advisors Limited Com accumulated 0.42% or 97,043 shares. CWM LLC's holdings in AbbVie were worth $5,296,000 as of its most recent SEC filing. (NYSE:ABBV) shares were sold by RICHMOND TIMOTHY J. AbbVie earned a media sentiment score of 0.24 on Accern's scale. Its down 0.05, from 0.85 in 2017Q2. It turned negative, as 55 investors sold ABBV shares while 640 reduced holdings.
Other hedge funds have also made changes to their positions in the company. 2,811 were accumulated by Baker Boyer Commercial Bank. Diligent Ltd Llc has 0.57% invested in AbbVie Inc. Univest Of Pennsylvania holds 1.96% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 37,600 shares. Nuveen Asset Mgmt Ltd Liability Corporation owns 658,987 shares or 0.38% of their USA portfolio. Fulton National Bank Na holds 74,376 shares. State Board Of Administration Of Florida Retirement Sys accumulated 105,310 shares. Finally, Naples Global Advisors LLC boosted its position in shares of AbbVie by 3.7% during the 4th quarter. (NYSE:ABBV) for 28,230 shares. Hbk Sorce Advisory Limited Com reported 0.18% of its portfolio in AbbVie Inc. (NYSE:ABBV). 3,820 were accumulated by Sonata Capital Grp Inc. Stevens First Principles Investment accumulated 95 shares. Bennicas & holds 1.33% of its portfolio in AbbVie Inc. (NYSE:ABBV). Waverton Investment Mgmt owns 0.06% invested in AbbVie Inc. During the same period in the prior year, the business earned $1.20 EPS. equities analysts predict that AbbVie Inc will post 7.48 earnings per share for the current year. During the same period past year, the company posted $1.20 earnings per share. The company reported $1.48 EPS for the quarter, topping the Zacks' consensus estimate of $1.44 by $0.04. ABBV's profit will be $2.83 billion for 16.75 P/E if the $1.78 EPS becomes a reality. Savant Capital LLC increased its stake in shares of AbbVie by 1.3% in the second quarter.
Analysts await PBF Energy Inc. (NYSE:RPAI) to report earnings on May, 1. They expect $0.41 EPS, up 305.00% or $0.61 from last year's $-0.2 per share. LPI's profit will be $57.46M for 9.33 P/E if the $0.24 EPS becomes a reality.
Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 9 Hold. Therefore 93% are positive. Hartline Investment Corp reported 0.24% in AbbVie Inc. (NASDAQ:AAOI) on Tuesday, October 3 with "Buy" rating. Barclays Capital has "Equal-Weight" rating and $9 target. The firm has "Hold" rating given on Tuesday, February 23 by Deutsche Bank. Piper Jaffray Companies reaffirmed a "buy" rating on shares of AbbVie in a research report on Tuesday, January 2nd. The rating was upgraded by JP Morgan on Friday, December 15 to "Overweight". Obermeyer Wood Investment Counsel Lllp now owns 7,093 shares of the company's stock valued at $514,000 after buying an additional 234 shares during the period. (NYSE:PBF) on Monday, November 14 to "Outperform" rating. The firm has "Buy" rating by DA Davidson given on Friday, August 4.
Investors sentiment decreased to 0.85 in 2017 Q3. Its down 0.30, from 1.25 in 2017Q2. It improved, as 23 investors sold LPI shares while 41 reduced holdings. 254.15 million shares or 0.31% more from 253.36 million shares in 2017Q2 were reported. Moreover, Parallax Volatility Advisers Ltd Partnership has 0% invested in Dillard's, Inc. (NYSE:ABBV). Sigma Planning Corporation invested 0.4% of its portfolio in AbbVie Inc. Sta Wealth Mgmt Limited Liability Company has 13,143 shares for 0.05% of their portfolio. Oppenheimer &, New York-based fund reported 232,965 shares. Tekla Capital Management Llc acquired 104,300 shares as Abbvie Inc.